OHSU in the news

Why children of color aren't getting the physical, speech therapy some need

USA Today March 08, 2023
USA Today covers disparities experienced by people of color in access to early intervention for newborns and toddlers with developmental delays and disabilities. Katharine Zuckerman, M.D., M.P.H., FAAP, says, “One of the things we consistently see in pediatrics is that children of color get less of everything. They get less antibiotics. They get less early intervention.”

Yachats Library and OHSU team up for four-year study of health benefits of regular walking

Yachats News March 07, 2023
Yachats News covers a “Rural Libraries and Walking Project” currently recruiting participants. Jim Winkle, M.P.H., says, “Everyone knows that exercise is good, and that walking is something most people can do. What we don’t know is this: Can using libraries in small towns be the key to implementing weekly walking groups? The NIH wants evidence to see if these programs work.” The study includes Yachats on the central Oregon coast, along with other rural communities around Oregon.

Research Suggests Errors Could Be Higher than Expected in Gene Edited Embryos

Inside Precision Medicine March 07, 2023
A commonly used scientific method to analyze a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research from OHSU presented this week at the Third International Summit on Human Genome Editing in London. Shoukhrat Mitalipov, Ph.D., says, “Gene repair has great potential, but these new results show that we have a lot of work to do”

Study reveals limitations in evaluating gene editing technology in human embryos

Science Daily March 07, 2023
A commonly used scientific method to analyze a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research from OHSU presented this week at the Third International Summit on Human Genome Editing in London. Shoukhrat Mitalipov, Ph.D., says, “Gene repair has great potential, but these new results show that we have a lot of work to do.”

FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency

BioPharma Dive March 06, 2023
BioPharma Dive covers a debate over the safety and effectiveness of a medication to prevent preterm labor; Aaron Caughey, M.D., Ph.D., says, “I would offer it and discuss with patients the evidence that we have, which is imperfect at the current time, and allow it to be what we call a ‘shared medical decision-making opportunity’ between the patient and the provider.”
See more stories